i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients

Jan 25, 2024

Time to read 4 Minutes

Download PDF

Back